REGROW BIOSCIENCES

We are dedicated to the research, development and commercialization of cell and stem cell-based products targeting degenerative and life-threatening diseases. Being true to our vision of becoming the world's largest stem cell and organ development factory, we are actively pursuing the next generation stem cell platform which promises to be universal and off-the-shelf. We are continuously innovating and publishing our original research in areas of hematopoietic transplantation, cell potency assays, HLA inventory, inhibitory effects of intraarticular steroid use, gene mutations offering a potential HIV cure and many more. We are hugely invested in the establishment and maintenance of high standards for ethical and corporate governance by partnering with the best of audit firms, certification bodies and independent ethics committees for research and trial purposes. Our clinical trial success speaks about our core expertise in assessment of diseases with unmet clinical need combined with our speed of research translating into safe and effective bed side treatment for patients.